CNTMF - Cansortium Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.4260
-0.0240 (-5.33%)
At close: 1:40PM EST
Stock chart is not supported by your current browser
Previous Close0.4500
Open0.4950
BidN/A x N/A
AskN/A x N/A
Day's Range0.4260 - 0.4950
52 Week Range0.2430 - 2.5000
Volume30,441
Avg. Volume26,625
Market Cap77.97M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.2410
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.23
  • Cansortium Restructures Approximately $25.0 Million of Near-Term Obligations, Significantly Improving Balance Sheet and Available Free Cash Flow to Fund Growth
    CNW Group

    Cansortium Restructures Approximately $25.0 Million of Near-Term Obligations, Significantly Improving Balance Sheet and Available Free Cash Flow to Fund Growth

    The Amended Note has no amortization, does not begin paying cash interest until April 1, 2020 , matures on December 1, 2022 and is exchangeable into common shares at any time at a price of $0.60 per share. Over $12.0 million of other contingent liabilities have also been restructured using shares previously returned by the founders, significantly reducing the Company's liabilities without dilution to existing shareholders.

  • Cansortium Inc. Announces Definitive Agreements to Sell Non-Core Canadian and Puerto Rican Operations
    PR Newswire

    Cansortium Inc. Announces Definitive Agreements to Sell Non-Core Canadian and Puerto Rican Operations

    Cansortium Inc. (CSE:TIUM.U) (OTCQB: CNTMF) ("Cansortium" or the "Company") and the recently-formed Special Committee of the Board of Directors today announced the signing of separate definitive agreements to sell the Company's non-core operations in Canada and Puerto Rico. Terms of the sales, which are each subject to customary conditions and regulatory approvals, were not disclosed.

  • Market Exclusive

    Cansortium Open 18th Fluent Medical Marijuana Location in Florida

    Cansortium (CSE: TIUM.U) (OTCQB: CNTMF), a provider of premium medical cannabis operating under the Fluent brand, continues to expand its presence in Florida. On Dec. 5, the company opened its 18th Florida dispensary in Lakeland, the largest city between Tampa and Orlando. Located at 4825 US Highway 98 North, along Interstate 4 between Tampa and Orlando, the […]The post Cansortium Open 18th Fluent Medical Marijuana Location in Florida appeared first on Market Exclusive.

  • PR Newswire

    Cansortium Announces Opening of its 18th Fluent™ Medical Marijuana Dispensary in Florida

    Cansortium Inc. ("Cansortium" or the "Company") (CSE: TIUM.U), (OTCQB: CNTMF) a vertically-integrated provider of premium-quality medical cannabis operating under the Fluent™ brand, continues to expand its Florida presence with the December 5th opening of its 18th Florida dispensary in a prime location in Lakeland, Florida, the largest city between Tampa and Orlando.

  • PR Newswire

    Cansortium Inc. Reports Third Quarter 2019 Financial Results; Revises Full Year 2019 Outlook

    Cansortium Inc. (CSE:TIUM.U) (OTCQB: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated provider of premium-quality medical cannabis, today announced financial results of the third quarter and nine months ended September 30, 2019. The Company's unaudited condensed interim consolidated financial statements and accompanying notes, along with the Management Discussion and Analysis (MD&A;) are available under the Company's profile on SEDAR at www.sedar.com and are also accessible through a link on the Investor Relations section of the Company's website.

  • CNW Group

    Cansortium Announces Opening Of Its 17th Fluent™ Medical Marijuana Dispensary In Florida

    MIAMI , Nov. 18, 2019 /PRNewswire/ -- Cansortium Inc. ("Cansortium" or the "Company") (TIUM-U.CN), (CNTMF) a vertically-integrated provider of premium-quality medical cannabis operating under the Fluent ™ brand, continues to expand its Florida footprint with the November 16th opening of a new Fluent dispensary in a prime location in Jacksonville, Florida . Located in Jacksonville's Arlington neighborhood at 9510 Atlantic Boulevard, the new 3,700 square-foot Jacksonville dispensary is the Company's 17th in Florida and its second in Jacksonville .

  • PR Newswire

    Cansortium Inc. Provides Update On Strength Of Its Florida Business, Announces The Return Of Approximately 26 Million Shares By Current And Former Senior Executives And Progress On Key Growth Initiatives

    MIAMI, Nov. 6, 2019 /PRNewswire/ -- Cansortium Inc. (TIUM-U.CN) (CNTMF) ("Cansortium" or the "Company") and the recently-formed Special Committee of the Board of Directors today announced the continued strong growth of its Florida business and shared progress on the implementation of key elements of its new growth plan to attract capital and strategic operating partners to drive sustainable, profitable growth. Cansortium's Florida business, which generates the vast majority of the Company's sales, generated record monthly sales of $2.8 million in October, representing growth of 43 percent over September. The Company also highlighted that, since June 2019, when Florida legalized the sale of smokable cannabis in licensed dispensaries, Cansortium's smokable premium flower products have grown to represent more than one-third of its Florida sales.

  • Newsfile

    Cansortium Announces a Reorganization of Senior Management and its Board of Directors, Significant Cost Reductions and the Prioritization and Acceleration of Growth in the U.S. Markets, Particularly Florida

    Miami, Florida--(Newsfile Corp. - October 22, 2019) - Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) ("Cansortium" or the "Company") and its Board of Directors (the "Board') have implemented a series of important corporate initiatives aimed at driving sustainable, profitable growth in the Company's core market of Florida by allocating the necessary capital to expand the number of dispensaries in the state to twenty by the end of 2019. These initiatives are also aimed at ensuring ...

  • Cansortium Inc. Announces Separation of CEO and Chairman Roles; Appoints Neal Hochberg as Chairman. Jose Hidalgo Continues as CEO to Focus Exclusively on Implementing the Company's Growth Initiatives
    CNW Group

    Cansortium Inc. Announces Separation of CEO and Chairman Roles; Appoints Neal Hochberg as Chairman. Jose Hidalgo Continues as CEO to Focus Exclusively on Implementing the Company's Growth Initiatives

    MIAMI , Oct. 15, 2019 /CNW/ - Cansortium Inc. (TIUM-U.CN) (CNTMF) ("Cansortium" or the "Company") today announced that its Board of Directors has elected independent director Neal Hochberg to serve as Non-Executive Chairman. Mr. Hochberg, a Certified Public Accountant, has a distinguished 40 year career in financial services. Recently, he was also appointed by the Supreme Court of Florida to membership on the Florida Board of Bar Examiners.

  • Cansortium Announces Opening of its 15th Fluent™ Medical Marijuana Dispensary in Florida and Plans to Have 6 Additional Open by the End of the Year
    CNW Group

    Cansortium Announces Opening of its 15th Fluent™ Medical Marijuana Dispensary in Florida and Plans to Have 6 Additional Open by the End of the Year

    MIAMI , Sept. 9, 2019 /CNW/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, continues to expand its Florida retail footprint with the September 9th opening of a new Fluent dispensary in a prime location in Cape Coral, FL. Cansortium's Chief Executive Officer Jose Hidalgo noted, "As one of the first five licensed operators in Florida - the state with the fastest-growing medical marijuana patient population in the U.S. – we continue to capitalize on our first-mover position, executing our growth plan by steadily expanding our dispensary network to enhance access to our premium-quality Fluent cannabis products for medical marijuana patients across the state.

  • Benzinga

    Cansortium Attributes Lower Q2 Revenue To 'Unexpected Delays,' Halves 2019 Outlook

    Cansortium achieved positive consolidated EBITDA of $1.8 million versus pro-forma EBITDA of $5.8 million in the second quarter of 2018. Consolidated adjusted EBITDA for the quarter was a loss of $2.6 million, compared to adjusted pro-forma positive EBITDA of $100,000 in the same quarter of the previous year. For the first half of 2019, the company reported consolidated revenue of $11.6 million, up by 37% from pro-forma revenue of $8.5 million in the first half of 2018.

  • Cansortium Inc. Reports Second Quarter 2019 Financial Results; Revises Full Year 2019 Outlook; Expects to Achieve Profitability in Early 2020
    CNW Group

    Cansortium Inc. Reports Second Quarter 2019 Financial Results; Revises Full Year 2019 Outlook; Expects to Achieve Profitability in Early 2020

    Cansortium Inc. Reports Second Quarter 2019 Financial Results; Revises Full Year 2019 Outlook; Expects to Achieve Profitability in Early 2020

  • Cansortium, Inc. Second Quarter Financial Results and Conference Call Scheduled for August 29
    PR Newswire

    Cansortium, Inc. Second Quarter Financial Results and Conference Call Scheduled for August 29

    MIAMI , Aug. 22, 2019 /PRNewswire/ - Cansortium Inc. (CSE:TIUM) (OTCQB: CNTMF) ("Cansortium" or the "Company"), a leading Florida -based medical cannabis company operating under the ...

  • Cansortium Commences Trading on OTCQB Venture Market, Bringing Increased Visibility and Enhanced Liquidity
    CNW Group

    Cansortium Commences Trading on OTCQB Venture Market, Bringing Increased Visibility and Enhanced Liquidity

    MIAMI, FL , Aug. 21, 2019 /CNW/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM) (CNTMF), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, announced today that it will begin trading today on the OTCQB Venture Market under the ticker "CNTMF".  This is an upgrade from the Company's previous classification on the Pink Open Market. Cansortium Chief Executive Officer Jose Hidalgo emphasized, "We are very pleased to begin trading on the OTCQB Venture Market less than five months after our initial public offering on the Canadian Securities Exchange, adding valuable visibility and additional liquidity for the benefit of our shareholders. U.S.-based investors can find current financial disclosure and Real-Time Level 2 quotes for the company at www.otcmarkets.com.

  • CNW Group

    Cansortium Announces Significant Expansion of its State-of-the-Art Tampa Cultivation Facility to Support Continued Growth in Florida Medical Marijuana Market

    MIAMI, FL , Aug. 19, 2019 /CNW/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, announced today that it has begun growing in Phase 2 at its state-of-the-art indoor medical marijuana cultivation facility in Tampa, Florida . Cansortium Chief Executive Officer Jose Hidalgo emphasized, "This Phase 2 expansion of our Tampa cultivation facility is another important step in support of our strategy to increase our revenue-generating capacity toward our goal of achieving operating profitability. "Expanding our Florida production capacity provides us with additional supply of high-quality cannabis to process into the wide variety of Fluent-branded medical marijuana products sold through our Florida dispensary network, currently comprising 15 dispensaries in key markets, which we expect to expand to more than 30 during 2020.